A detailed history of California State Teachers Retirement System transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 5,961 shares of CRBU stock, worth $10,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,961
Previous 5,961 -0.0%
Holding current value
$10,729
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.62 - $5.05 $3,680 - $11,473
-2,272 Reduced 27.6%
5,961 $9,000
Q1 2024

May 15, 2024

SELL
$4.82 - $8.26 $25,266 - $43,298
-5,242 Reduced 38.9%
8,233 $42,000
Q4 2023

Feb 13, 2024

SELL
$3.58 - $6.25 $10,768 - $18,800
-3,008 Reduced 18.25%
13,475 $77,000
Q3 2023

Nov 14, 2023

SELL
$4.08 - $8.14 $9,955 - $19,861
-2,440 Reduced 12.89%
16,483 $78,000
Q2 2023

Aug 21, 2023

SELL
$4.04 - $5.47 $180,996 - $245,061
-44,801 Reduced 70.3%
18,923 $80,000
Q1 2023

May 09, 2023

SELL
$4.3 - $7.78 $4,050 - $7,328
-942 Reduced 1.46%
63,724 $338,000
Q4 2022

Feb 14, 2023

BUY
$5.57 - $11.01 $4,121 - $8,147
740 Added 1.16%
64,666 $406,000
Q3 2022

Nov 18, 2022

SELL
$5.34 - $12.79 $1,965 - $4,706
-368 Reduced 0.57%
63,926 $674,000
Q2 2022

Aug 15, 2022

BUY
$5.1 - $9.74 $113,026 - $215,857
22,162 Added 52.6%
64,294 $349,000
Q1 2022

May 16, 2022

BUY
$8.42 - $15.32 $89,614 - $163,050
10,643 Added 33.8%
42,132 $387,000
Q4 2021

Feb 15, 2022

BUY
$14.59 - $23.26 $308,257 - $491,437
21,128 Added 203.92%
31,489 $475,000
Q3 2021

Nov 15, 2021

BUY
$15.75 - $30.29 $163,185 - $313,834
10,361 New
10,361 $247,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $110M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.